The people of Albany may have thought that over-the counter medications were completely safe, but after a major pharmaceutical company reported that its manufacturing plant had erroneously been mixing medications, people in upstate New York may need to check what they're taking for headaches. The company has recently recalled four products after it was discovered that the defective drugs could potentially harm consumers who believe they are taking the medications they purchased. The company, Novartis Consumer Health, has issued a recall for Excedrin, Bufferin, Gas-X Prevention and NoDoz.
When there are manufacturing problems with drugs, consumers could face a bevy of unintended reactions, medical complications or even death. It is possible that a defective medication could cause an extreme allergic reaction or could interfere with a person's other medication. If a consumer can point to his or her medication as the source of the problem, however, he or she can file a products liability claim against the company who manufactured the defective product. Although you may not know how to start a lawsuit against a large pharmaceutical company for defective medicine, an experienced dangerous and defective products attorney can take steps to holding the manufacturer accountable.
Unfortunately for Albany residents, Novartis has admitted its manufacturing errors in some extremely common over-the-counter medications. The company said that the affected products may have tablets from its other products in the bottle, which could alter how much medicine a consumer actually believes he or she is taking. If, for example, someone were to take two Excedrin capsules and two NoDoz tablets, but one of the NoDoz tablets was actually an Excedrin capsule, the consumer would have accidentally ingested too much of one medication and not enough of the other.
The company has also reported including chipped and broken tablets in the different pill bottles.
Source: Pioneer Press, "Novartis recalls Excedrin, NoDoz, Bufferin, Gas-X Prevention over reports of plant malfunction," Jan. 9, 2012